POU3F3-related disorder: Defining the phenotype and expanding the molecular spectrum.
POU3F3
autism
cupped ears
epilepsy
neurodevelopmental disorder
Journal
Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
06
04
2023
received:
23
01
2023
accepted:
24
04
2023
pmc-release:
01
08
2024
medline:
5
7
2023
pubmed:
11
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
POU3F3 variants cause developmental delay, behavioral problems, hypotonia and dysmorphic features. We investigated the phenotypic and genetic landscape, and genotype-phenotype correlations in individuals with POU3F3-related disorders. We recruited unpublished individuals with POU3F3 variants through international collaborations and obtained updated clinical data on previously published individuals. Trio exome sequencing or single exome sequencing followed by segregation analysis were performed in the novel cohort. Functional effects of missense variants were investigated with 3D protein modeling. We included 28 individuals (5 previously published) from 26 families carrying POU3F3 variants; 23 de novo and one inherited from an affected parent. Median age at study inclusion was 7.4 years. All had developmental delay mainly affecting speech, behavioral difficulties, psychiatric comorbidities and dysmorphisms. Additional features included gastrointestinal comorbidities, hearing loss, ophthalmological anomalies, epilepsy, sleep disturbances and joint hypermobility. Autism, hearing and eye comorbidities, dysmorphisms were more common in individuals with truncating variants, whereas epilepsy was only associated with missense variants. In silico structural modeling predicted that all (likely) pathogenic variants destabilize the DNA-binding region of POU3F3. Our study refined the phenotypic and genetic landscape of POU3F3-related disorders, it reports the functional properties of the identified pathogenic variants, and delineates some genotype-phenotype correlations.
Identifiants
pubmed: 37165752
doi: 10.1111/cge.14353
pmc: PMC10330344
mid: NIHMS1897443
doi:
Substances chimiques
POU3F3 protein, human
0
POU Domain Factors
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
186-197Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : K23 NS119666
Pays : United States
Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Mol Genet Genomic Med. 2021 Jul;9(7):e1686
pubmed: 33949806
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Am J Hum Genet. 2019 Aug 1;105(2):403-412
pubmed: 31303265
Nat Commun. 2017 Aug 9;8(1):236
pubmed: 28794409
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Hum Mutat. 2016 May;37(5):447-56
pubmed: 26841357
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Sci Rep. 2016 Feb 15;6:20818
pubmed: 26877091
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Epilepsia. 2022 Jun;63(6):1333-1348
pubmed: 35503715
Am J Med Genet A. 2021 May;185(5):1554-1560
pubmed: 33645921
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
Annu Rev Biochem. 2007;76:51-74
pubmed: 17352659
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Dev Cell. 2006 Dec;11(6):831-44
pubmed: 17141158
Nat Genet. 2004 Aug;36(8):801-8
pubmed: 15284851
Proteins. 2011 Feb;79(2):674-7
pubmed: 21117060
Genome Med. 2021 Feb 22;13(1):31
pubmed: 33618777